WHITFIELD ROY A

Average Profitability
51.06%
Insider Buys Quantity
3
Insider Buys Sum
$1.84M
Insider Sells Quantity
48
Insider Sells Sum
$22.6M

Insider Activity of WHITFIELD ROY A

The largest purchase of all time was on 2017-08-10 and amounted to 70000 shares of Nektar Therapeutics for $1.26M.

The largest sale of all time was on 2013-11-18 and amounted to 50000 shares of Incyte Corporation for $2.37M.

Biography of WHITFIELD ROY A

No biography is available at this moment.

2023-06-14SaleNektar Therapeutics
NKTR
director
30,000
0.0164%
$0.57$17,100+8.29%
2018-06-06PurchaseNektar Therapeutics
NKTR
director
6,800
0.0039%
$59.37$403,720-31.63%
2018-06-05PurchaseNektar Therapeutics
NKTR
director
3,200
0.0018%
$55.22$176,704-26.68%
2017-08-10PurchaseNektar Therapeutics
NKTR
director
70,000
0.0448%
$17.95$1.26M+211.48%
2016-08-12SaleIllumina, Inc.
ILMN
director
4,000
0.0027%
$167.22$668,880+1.75%
2016-06-13SaleIllumina, Inc.
ILMN
director
3,800
0.0026%
$140.44$533,672+17.15%
2016-04-12SaleIllumina, Inc.
ILMN
director
4,000
0.0027%
$170.00$680,000-12.45%
2016-02-12SaleIllumina, Inc.
ILMN
director
3,750
0.0025%
$140.30$526,125+4.39%
2015-12-14SaleIllumina, Inc.
ILMN
director
3,750
0.0026%
$175.07$656,513-13.98%
2015-09-04SaleIllumina, Inc.
ILMN
director
4,500
0.0031%
$192.63$866,835-19.55%
2015-08-05SaleIllumina, Inc.
ILMN
director
4,500
0.0031%
$215.22$968,490-27.9%
2015-07-06SaleIllumina, Inc.
ILMN
director
4,500
0.0031%
$218.11$981,478-26.71%
2015-06-05SaleIllumina, Inc.
ILMN
director
4,500
0.0031%
$207.49$933,705-19.08%
2015-05-05SaleIllumina, Inc.
ILMN
director
4,500
0.0031%
$188.42$847,890-5.75%
2015-04-06SaleIllumina, Inc.
ILMN
director
4,600
0.0032%
$181.32$834,072+1.4%
2015-03-05SaleIllumina, Inc.
ILMN
director
4,600
0.0031%
$194.68$895,508-5.97%
2014-11-17SaleIllumina, Inc.
ILMN
director
4,000
0.0029%
$178.26$713,040+5.61%
2014-08-15SaleIllumina, Inc.
ILMN
director
4,000
0.0028%
$169.28$677,120+13.4%
2014-05-15SaleIllumina, Inc.
ILMN
director
4,000
0.003%
$143.71$574,840+27.15%
2014-02-24SaleIllumina, Inc.
ILMN
director
2,000
0.0015%
$175.26$350,520-3.25%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.